Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease

Authors: M Malik, A Falkentoft, J Jensen, C Andersson, S L Parveen, L Koeber, M E M Schou

Published: 2022-10-15

DOI: 10.1093/eurheartj/ehac544.2692

Source: Full article


Abstract

Abstract